Amphion Innovations PLC Director/PDMR Shareholding (9668S)
November 13 2013 - 11:33AM
UK Regulatory
TIDMAMP
RNS Number : 9668S
Amphion Innovations PLC
13 November 2013
Directors' Dealings
Directors Receive Shares in Lieu of Fees
London and New York, 13 November 2013- Amphion Innovations plc
(the "Company") (LSE: AMP), the developer of medical and technology
businesses, announces that the Company has today issued 663,821
ordinary shares, representing 0.45% of the enlarged issued share
capital, to certain of its Board members as their directors' fees
for the fourth quarter of 2012 and the first three quarters of
2013, priced at 4.175 pence, being the average of the closing
mid-market price for the five days leading up to the market close
on 12 November 2013.Following this issue, the directors'
shareholdings in the Company are as follows:
Director Number of New Shares Total Shareholding Percentage of voting rights
R. James Macaleer 501,321 24,480,266 16.666%
Gerard Moufflet 162,500 862,500 0.587%
Director, Anthony Henfrey waived his fees for the fourth quarter
of 2012 as well as for the first three quarters of 2013.
Admission of the 663,821 new ordinary shares, ranking pari passu
with the existing ordinary shares, is expected on 19 November 2013.
Following this allotment the total issued share capital of the
Company will increase to 146,884,071 ordinary shares with each
share holding one voting right.
For further information please contact
Amphion Innovations
Charlie Morgan
+1 212 210 6224
Novella Communications
Tim Robertson / Ben Heath
+44 020 3151 7008
Panmure Gordon Limited
Freddy Crossley / Grishma Patel (Corporate Finance)
Adam Pollock (Corporate Broking)
+44 020 7886 2500
About Amphion Innovations plc
Amphion (LSE: AMP) builds shareholder value in emerging
companies in the medical and technology sectors, by using a
focused, hands-on company building approach, based on decades of
experience in both the US and UK. Amphion has significant
shareholding in 7 Partner Companies developing proven technologies
targeting substantial commercial marketplaces. The Amphion model
has been refined to optimise the commercialisation of patents and
other intellectual property within the Partner Companies. The
Partner Companies collectively own or control over 200 separately
identified pieces of intellectual property, a number which grows
rapidly each year.
On the web: www.amphionplc.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSQXLFFXFFXFBL
Amphion Innovations (LSE:AMP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amphion Innovations (LSE:AMP)
Historical Stock Chart
From Apr 2023 to Apr 2024